[1]
2024. TREATMENT OF PATISIRAN IN PATIENTS WHO HAS TRANSTHYRETIN CARDIAC AMYLOIDOSIS. INTERNATIONAL JOURNAL OF RECENTLY SCIENTIFIC RESEARCHER’S THEORY. 2, 2 (Feb. 2024), 283–292.